Chapter Five - Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease

Publication date: 2018Source: International Review of Neurobiology, Volume 141Author(s): Edoardo R. de Natale, Flavia Niccolini, Heather Wilson, Marios PolitisAbstractParkinson's disease (PD) is a neurodegenerative disease characterized by the degeneration of dopaminergic nigrostriatal connections which is recognized as the major pathophysiological event underlying the onset of motor symptoms. Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) imaging allow the study of these connections in vivo at a molecular level. Several radiotracers have been developed targeting the synthesis and metabolism of dopamine and dopaminergic receptors to investigate the nigrostriatal pathway in vivo. Molecular imaging has greatly increased our knowledge on the progression and natural history of PD, as well as the development of motor and non-motor symptoms. PET molecular imaging could be a reliable biomarker to aid earlier diagnosis and for monitoring disease progression. Furthermore, PET imaging could be used as outcome measure in the design of clinical trials testing novel pharmacological compounds aiming to slow, and ultimately halt, disease progression.
Source: International Review of Neurobiology - Category: Neuroscience Source Type: research